Levine S M, Anzueto A, Gibbons W J, Calhoon J H, Jenkinson S G, Trinkle J K, Bryan C L
Department of Medicine, University of Texas Health Science Center, San Antonio.
Chest. 1993 Feb;103(2):444-8. doi: 10.1378/chest.103.2.444.
Single lung transplantation (SLT) has become a therapeutic option for the treatment of end-stage obstructive lung disease. Between January 1989 and June 1990, there were 14 patients with end-stage obstructive lung disease who underwent SLT. Eleven of these patients were surviving at 1 year following transplantation. Three of the patients had received left-sided SLT, and eight had received right-sided SLT. In the patients receiving left-sided SLT, the native right lung radiographically appeared to compress the left lung graft. In the patients receiving right-sided SLT, the native left lung did not appear to compress the right lung graft. We hypothesized that right SLT may provide a functional advantage over left SLT for patients with obstructive lung disease. We compared pulmonary function test results before and after transplantation (approximately 3 and 12 months) and compared quantitative ventilation-perfusion lung scan results between the patients with left SLT and those with right SLT. Additionally, we compared graded-exercise test results at 3 and 12 months after transplant between the two groups. Our data revealed no statistical difference in pulmonary function test results or graded-exercise test results between the two groups, although patients undergoing right SLT showed greater increases in FEV1 and forced vital capacity than those undergoing left SLT. Quantitative ventilation and perfusion were greater to the graft in patients receiving right-sided SLT than in patients receiving left-sided SLT, most likely due to the larger size of the right lung. We conclude that there is no functional difference between patients undergoing left or right SLT for end-stage obstructive lung disease.
单肺移植(SLT)已成为治疗终末期阻塞性肺疾病的一种治疗选择。1989年1月至1990年6月期间,有14例终末期阻塞性肺疾病患者接受了单肺移植。其中11例患者移植后1年仍存活。3例患者接受了左侧单肺移植,8例接受了右侧单肺移植。接受左侧单肺移植的患者,其原生右肺在影像学上似乎压迫左肺移植肺。接受右侧单肺移植的患者,其原生左肺似乎未压迫右肺移植肺。我们推测,对于阻塞性肺疾病患者,右侧单肺移植可能比左侧单肺移植具有功能优势。我们比较了移植前后(约3个月和12个月)的肺功能测试结果,并比较了左侧单肺移植患者和右侧单肺移植患者的定量通气灌注肺扫描结果。此外,我们还比较了两组患者移植后3个月和12个月的分级运动测试结果。我们的数据显示,两组患者的肺功能测试结果或分级运动测试结果无统计学差异,尽管接受右侧单肺移植的患者FEV1和用力肺活量的增加幅度大于接受左侧单肺移植的患者。接受右侧单肺移植患者的移植肺的定量通气和灌注大于接受左侧单肺移植的患者,这很可能是由于右肺体积较大。我们得出结论,对于终末期阻塞性肺疾病患者,接受左侧或右侧单肺移植在功能上没有差异。